Real-life effectiveness of beclomethasone diproprionate/formoterol extra-fine combination in adult patients with persistent asthma
G. G. Brusselle, P. Van Den Brande, R. Peché, B. Fonteyn, D. Iacono, M. Blockmans, J. Bruhwyler, W. Hollanders (Ghent, Duffel, Montigny-le-Tilleul, Zutendaal, Malmedy, Court-Saint-Etienne, Ecaussinnes, Brussels, Belgium)
Source: Annual Congress 2011 - Asthma management and response
Session: Asthma management and response
Session type: Thematic Poster Session
Number: 3956
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. G. Brusselle, P. Van Den Brande, R. Peché, B. Fonteyn, D. Iacono, M. Blockmans, J. Bruhwyler, W. Hollanders (Ghent, Duffel, Montigny-le-Tilleul, Zutendaal, Malmedy, Court-Saint-Etienne, Ecaussinnes, Brussels, Belgium). Real-life effectiveness of beclomethasone diproprionate/formoterol extra-fine combination in adult patients with persistent asthma. Eur Respir J 2011; 38: Suppl. 55, 3956
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Efficacy, safety and cost of using beclomethason dipropionate in patients with persistent moderate bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004
Efficacy and safety of the new beclomethasone dipropionate/formoterol combination vs. fluticasone propionate/salmeterol pMDIs in moderate to severe persistent asthma Source: Eur Respir J 2006; 28: Suppl. 50, 205s Year: 2006
Assessment of long-term effects of combined extra-fine beclomethasone and formoterol treatment in asthma patients using functional imaging Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010
Clinical efficacy of seretide and beclomethasone dipropionate in patients with corticosteroid-dependent bronchial asthma and quality of life Source: Eur Respir J 2004; 24: Suppl. 48, 285s Year: 2004
The clinical effectiveness of HFA-beclomethasone dipropionate in children with moderate asthma Source: Eur Respir J 2004; 24: Suppl. 48, 166s Year: 2004
Extrafine beclomethasone dipropionate aerosol therapy shows promising improved effect in treatment of children with stable asthma Source: Eur Respir J 2004; 24: Suppl. 48, 378s Year: 2004
Effectiveness and safety of fluticasone propionate/salmeterol 250/50mcg administered once daily to patients with persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 309s Year: 2004
Efficacy and safety of long-term therapy with Salamol combined with Beclason versus Salamol only in patients with mild persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 42s Year: 2002
Inhalation of beclomethason dipropionate spray compared with theophilline as primary treatment for chronic mild-to-moderate asthma Source: Eur Respir J 2002; 20: Suppl. 38, 42s Year: 2002
Comparative clinical study of addition theophylline to low-dose inhaled beclomethasone dipropionate and medium-dose inhaled beclomethasone dipropionate in patients with mild-to-moderate persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001
A pharmaco-epidemiological audit of beclomethasone dipropionate extrafine aerosol in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 471s Year: 2002
Efficacy and safety of ciclesonide compared with fluticasone propionate or budesonide in adolescent patients with persistent asthma Source: Eur Respir J 2007; 30: Suppl. 51, 458s Year: 2007
Comparative efficacy and costs of the treatment of moderate to severe persistent asthma with a new dry-powder inhaled beclomethasone dipropionate and formoterol combination Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013
HFA vs CFC beclomethasone dipropionate – comparative effectiveness in asthma management Source: Eur Respir J 2006; 28: Suppl. 50, 498s Year: 2006
Efficacy and safety of budesonide/formoterol comparing with budesonide and theophylline in Japanese adult patients with asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008
HFA beclomethasone dipropionate (HFA-BDP) extrafine aerosol and formoterol in optimizing the management of bronchial asthma at children Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005
Efficacy and safety of ciclesonide compared with fluticasone propionate in patients with moderate to severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006
Long-term safety of inhaled formoterol in adult asthma patients Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009
Comparison of a new extrafine beclomethasone dipropionate HFA134a-formulated pMDI with a standard BDP CFC pMDI in adults with moderate persistent asthma Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006
Improved and maintained asthma control with once-daily budesonide/formoterol single inhaler therapy in mild-to-moderate persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 21s Year: 2001